PTAB Invalidates Claims In Durezol Eye Drops Patent
Akorn scored a win at the Patent Trial and Appeal Board on Tuesday, when the board ruled that the drugmaker had shown several claims in a patent related to Alcon Laboratories' Durazol eye...To view the full article, register now.
Already a subscriber? Click here to view full article